Bertini Roberto, Roscigno Marco, Freschi Massimo, Strada Elena, Petralia Giovanni, Pasta Alessandra, Matloob Rayan, Sozzi Francesco, Da Pozzo Luigi, Colombo Renzo, Guazzoni Giorgio, Doglioni Claudio, Montorsi Francesco, Rigatti Patrizio
Department of Urology, Vita-Salute University San Raffaele, Milan, Italy.
J Urol. 2009 May;181(5):2027-32. doi: 10.1016/j.juro.2009.01.048. Epub 2009 Mar 14.
According to the 2002 American Joint Committee on Cancer TNM classification, perinephric and renal sinus fat invasion are classified as pT3a renal cell carcinoma. However, only a few studies have assessed the impact of sinus fat invasion on patient survival and with controversial results. We analyzed the impact of sinus fat invasion on cancer specific survival in a cohort of patients with pT3a clear cell renal cell carcinoma.
We retrospectively analyzed data on 115 consecutive patients treated with open radical nephrectomy for unilateral, sporadic pT3a clear cell renal cell carcinoma at our department from 1989 to 2006. All pathological specimens were rereviewed by a single uropathologist. The prognostic role of sinus fat invasion in cancer specific survival was assessed by Cox proportional hazards regression models.
Ten patients had direct ipsilateral adrenal invasion and were excluded from analysis. A total of 105 patients with clear cell renal cell carcinoma were evaluated. Median followup was 38 months. In the overall population sinus fat invasion did not reach independent predictive status in terms of cancer specific survival on multivariate Cox regression analysis after adjusting for age, performance status, tumor dimension, tumor grade, synchronous metastases, nodal involvement, sarcomatoid differentiation and coagulative necrosis. In the subset of patients with pNx/pN0 M0 (83) the actuarial 5-year cancer specific survival was 71.9% and 45.5% for those with perinephric fat invasion only and sinus fat invasion, respectively (p = 0.025). Sinus fat invasion achieved an independent predictive role on multivariable Cox regression analysis (p = 0.048, HR 2.06).
Sinus fat invasion in clear cell renal cell carcinoma significantly affects cancer specific survival in patients without nodal or distant metastases. However, sinus fat invasion is not associated with worse cancer specific survival in cases of metastatic disease.
根据2002年美国癌症联合委员会TNM分类,肾周脂肪和肾窦脂肪侵犯被归类为pT3a期肾细胞癌。然而,仅有少数研究评估了肾窦脂肪侵犯对患者生存的影响,且结果存在争议。我们分析了肾窦脂肪侵犯对一组pT3a期透明细胞肾细胞癌患者癌症特异性生存的影响。
我们回顾性分析了1989年至2006年在我院接受开放性根治性肾切除术治疗单侧、散发性pT3a期透明细胞肾细胞癌的115例连续患者的数据。所有病理标本均由一名泌尿病理学家重新检查。通过Cox比例风险回归模型评估肾窦脂肪侵犯在癌症特异性生存中的预后作用。
10例患者存在同侧肾上腺直接侵犯,被排除在分析之外。共评估了105例透明细胞肾细胞癌患者。中位随访时间为38个月。在总体人群中,在调整年龄、体能状态、肿瘤大小、肿瘤分级、同步转移、淋巴结受累、肉瘤样分化和凝固性坏死因素后,多因素Cox回归分析显示肾窦脂肪侵犯在癌症特异性生存方面未达到独立预测地位。在pNx/pN0 M0(83例)患者亚组中,仅存在肾周脂肪侵犯和存在肾窦脂肪侵犯患者的5年精算癌症特异性生存率分别为71.9%和45.5%(p = 0.025)。肾窦脂肪侵犯在多变量Cox回归分析中具有独立预测作用(p = 0.048,HR 2.06)。
透明细胞肾细胞癌中的肾窦脂肪侵犯显著影响无淋巴结或远处转移患者的癌症特异性生存。然而,在转移性疾病病例中,肾窦脂肪侵犯与较差的癌症特异性生存无关。